4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0001724521-23-000011
Chief Operating Officer sold 21,369 shares at $19.99 ($427,166)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Jarrett Jennifer · Chief Operating Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-09-22 | Sale : show line 1 in the form 10b5-1 | −21,369 | $19.99 | $427,166 | 302,691 | D |
| Open-market sales · 21,369 sh · avg $19.99 · $427,166 | ||||||
Loading xslF345X05/wk-form4_1695760547.xml…